Abiopharma

🔍 Gebbia John M. (Executive)

Company: SIEBERT FINANCIAL CORP (SIEB)

Report Date: 2026-08-26

Detailed Transactions and Holdings:

• Holds 0 shares of Common Stock, $0.01 par value per share (Direct)
  Date: 2026-08-26 | Code: H | shares_owned_after: 1,921,891.00 | Footnotes: F1
• Holds 0 shares of Common Stock, $0.01 par value per share (Direct)
  Date: 2026-08-26 | Code: H | nature_of_ownership: See Footnote | shares_owned_after: 490,000.00 | Footnotes: F2
• Holds 0 shares of Common Stock, $0.01 par value per share (Direct)
  Date: 2026-08-26 | Code: H | nature_of_ownership: Control Group | shares_owned_after: 17,060,603.00 | Footnotes: F3

Footnotes:

• F1: The Reporting Person owns 1,921,891 shares of Issuer common stock.
• F2: The Reporting Person's various family members own 490,000 shares of Issuer common stock. The Reporting Person disclaims beneficial ownership of such shares of Issuer common stock, except to the extent of the Reporting Person's pecuniary interest therein.
• F3: The Reporting Person is part of a control group consisting of family members of the Reporting Person. Members of the control group gifted 22,500 shares of Issuer common stock to individuals not included within the control group. Additionally, a family member of a member in the control group acquired 15,000 shares of Issuer common stock. These events resulted in a net decrease of 7,500 shares of Issuer common stock to the control group. The Reporting Person disclaims beneficial ownership of such shares of Issuer common stock, except to the extent of the Reporting Person's pecuniary interest therein.